Publication: Post-Treatment Surveillance for Lymphatic Filariasis in Plateau and Nasarawa States, Nigeria: Results of Transmission Assessment Surveys
08 June 2020
In order to confirm that transmission recrudescence or importation does not occur for lymphatic filariasis (LF) after mass drug administration (MDA), the WHO recommends post-treatment surveillance. This research article covers the transmission assessment surveys (TASs) conducted at 2 to 3-year intervals after TAS-1 stop-MDA surveys. Results from the TASs indicate that elimination of transmission has been achieved in Plateau and Nasarawa, Nigeria.
Eigege et al., 2020 (321.96 KB)